Compare Enveric Biosciences Inc (ENVB) vs YieldMax TSLA Option Income Strategy ETF (TSLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs YieldMax TSLA Option Income Strategy ETF — how do they compare? Enveric Biosciences Inc trades at $1.43 (market cap $5.32M), while YieldMax TSLA Option Income Strategy ETF trades at $26.09. Which is the better fit depends on your goals.
| ENVB | TSLY | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $17.40 | $48.25 |
52-Week Low | $1.28 | $26.16 |
Enterprise Value | $408.82K | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
TSLY trades at $26.48, down 1.3% over the past day, with a bearish technical signal from moving averages and neutral oscillators. The ETF maintains a high distribution yield, with recent weekly dividends ranging from $0.26 to $0.52. Recent news highlights consistent distribution announcements from YieldMax, though coverage notes the fund's capped upside and volatility risks tied to its synthetic TSLA exposure.
The outlook for TSLY hinges on its ability to sustain high yields through option income strategies, but faces risks from Tesla's stock volatility and potential capital erosion. Investors should weigh the attractive income against significant downside exposure and limited growth potential in a bearish technical environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About YieldMax TSLA Option Income Strategy ETF
TSLY is an actively managed ETF that seeks to provide high monthly income by employing a synthetic covered call strategy on Tesla, Inc. (TSLA). It does not own Tesla stock directly; instead, it uses a combination of call and put options to simulate long exposure while simultaneously selling call options to collect premiums. It is designed for income-focused investors who are willing to trade TSLA's potential upside for immediate, aggressive yield.
Read more on TSLY →
